National Drug Strategy
National Drug Strategy

Australia's National Drug Strategy beyond 2009: consultation paper

Foreword

prev pageTOC |next page

Australia's National Drug Strategy 2004–2009 is in its final year of implementation. The Strategy has been evaluated by independent experts under the auspices of the Ministerial Council on Drug Strategy (MCDS). The evaluation found that the Strategy and its three pillars of supply, demand and harm reduction are fundamentally sound and have been vital to the success of the Strategy in reducing the prevalence of, and harms from, drug use in Australia over a long period.

Nonetheless, significant harms from drug use continue to occur in Australia and new trends are emerging. This Consultation Paper aims to identify emerging issues and seek input from expert stakeholders and the broader community on directions for the next phase of the Strategy 2010–2015.

The Paper has been prepared on behalf of the MCDS by the Intergovernmental Committee on Drugs National Drug Strategy Development Working Group (Appendix 1 details organisational membership on the Working Group). The MCDS invites feedback on the paper. In particular the Council is interested in:

The MCDS will consider your feedback in response to this paper in developing a draft of the National Drug Strategy 2010-2015, which will be released for further consultation in the first half of 2010.

prev pageTOC |next page